EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C50H70N8O13 |
| Net Charge | 0 |
| Average Mass | 991.153 |
| Monoisotopic Mass | 990.50623 |
| SMILES | CC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]2CC[C@@H](O)N(C2=O)[C@@H](Cc2ccccc2)C(=O)N(C)[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)O[C@@H]1C)[C@@H](C)O |
| InChI | InChI=1S/C50H70N8O13/c1-26(2)23-35-43(63)51-34-20-21-39(62)58(48(34)68)38(25-31-13-10-9-11-14-31)49(69)56(8)37(24-32-16-18-33(61)19-17-32)45(65)53-40(27(3)4)50(70)71-29(6)42(47(67)52-35)55-46(66)41(28(5)59)54-44(64)36-15-12-22-57(36)30(7)60/h9-11,13-14,16-19,26-29,34-42,59,61-62H,12,15,20-25H2,1-8H3,(H,51,63)(H,52,67)(H,53,65)(H,54,64)(H,55,66)/t28-,29-,34+,35+,36+,37+,38+,39-,40+,41+,42+/m1/s1 |
| InChIKey | NGRWMTIDCSTQOO-XADDPKOHSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Lyngbya (ncbitaxon:28073) | - | PubMed (18693761) |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. EC 3.4.21.1 (chymotrypsin) inhibitor An EC 3.4.21.* (serine endopeptidase) inhibitor that interferes with the action of chymotrypsin (EC 3.4.21.1). serine protease inhibitor Any protease inhibitor that restricts the action of a serine protease. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| kempopeptin A (CHEBI:66142) has role EC 3.4.21.1 (chymotrypsin) inhibitor (CHEBI:64943) |
| kempopeptin A (CHEBI:66142) has role metabolite (CHEBI:25212) |
| kempopeptin A (CHEBI:66142) has role serine protease inhibitor (CHEBI:64926) |
| kempopeptin A (CHEBI:66142) is a cyclodepsipeptide (CHEBI:35213) |
| kempopeptin A (CHEBI:66142) is a macrocycle (CHEBI:51026) |
| IUPAC Name |
|---|
| 1-acetyl-L-prolyl-N-[(2S,5S,8S,11R,12S,15S,18S,21R)-2-benzyl-21-hydroxy-5-(4-hydroxybenzyl)-4,11-dimethyl-15-(2-methylpropyl)-3,6,9,13,16,22-hexaoxo-8-(propan-2-yl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docos-12-yl]-L-threoninamide |
| Registry Numbers | Sources |
|---|---|
| Reaxys:19205157 | Reaxys |
| Citations |
|---|